IN8bio, Inc. (INAB) Tops Q3 EPS by 2c

IN8bio, Inc. (NASDAQ: INAB) reported Q3 EPS of ($0.15), $0.02 better than the analyst estimate of ($0.17).

For earnings history and earnings-related data on IN8bio, Inc. (INAB) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• Applied Materials (AMAT) PT Raised to $700 at Bernstein SocGen Group
• Target (TGT) PT Raised to $146 at Piper Sandler